In cirrhosis, activation of the farnesoid X receptor can upregulate fibroblast growth factor 19, suppress hepatic bile acid synthesis, and strengthen epithelial barrier function (Sonne, 2021). The gene discussed is NR1H4; the disease is Cirrhosis.